Triptorelin depot stimulation test for central precocious puberty

Journal of Pediatric Endocrinology and Metabolism

Volumn 26, Issue 7-8, 2013, Pages 631-634

  Strich, David ^a   Kvatinsky, Noa ^b   Hirsch, Harry J ^c   Gillis, David ^d  

^a CLALIT HEALTH SERVICES   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c SHAARE ZEDEK MEDICAL CENTER   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Central precocious puberty; Gonadotropins; Triptorelin

Indexed keywords

ESTROGEN; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; TESTOSTERONE; TRIPTORELIN;

ARTICLE; BLOOD SAMPLING; BONE AGE; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CONGENITAL ADRENAL HYPERPLASIA; DRUG EFFICACY; ESTROGEN BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; GROWTH RATE; HUMAN; INJECTION; LUTEINIZING HORMONE BLOOD LEVEL; MALE; PATIENT MONITORING; PRECOCIOUS PUBERTY; PRESCHOOL CHILD; PROVOCATION TEST; RETROSPECTIVE STUDY; SCHOOL CHILD; TESTOSTERONE BLOOD LEVEL;

CHILD; CHILD, PRESCHOOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MALE; PUBERTY, PRECOCIOUS; RETROSPECTIVE STUDIES; TRIPTORELIN PAMOATE;

EID: 84881498287     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2012-0015     Document Type: Article

References (13)

1. Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR (on behalf of the members of the ESPE-LWPES GnRH Analogs Consensus Conference Group). Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 2009;123:e752 - 62.
2. Kulin HE, Reiter EO. Gonadotropins during childhood and adolescence: A review. Pediatrics 1973;51:260 - 71.
3. Styne DM, Harris DA, Egli CA, Conte FA, Kaplan SL, et al. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary- gonadal axis. J Clin Endocrinol Metab 1985;61:142 - 51.
4. Hirsch HJ, Lahlou N, Gillis D, Strich D, Rosenberg-Hagen B, et al. Free alpha-subunit is the most sensitive marker of gonadotropin recovery after treatment of central precocious puberty with the histrelin implant. J Clin Endocrinol Metab 2010;95:2841 - 4.
5. Ibáñez L, Potau N, Zampolli M, Virdis R, Gussinyé M, et al. Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test. J Clin Endocrinol Metab 1994;78:30 - 5.
6. Brito VN, Latronico AC, Arnhold IJ, Mendonca BB. A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls. J Clin Endocrinol Metab 2004;89:4338 - 42.
7. Acharya SV, Gopal RA, George J, Bandgar TR, Menon PS, et al. Utility of single luteinizing hormone determination 3 h after depot leuprolide in monitoring therapy of gonadotropin-dependent precocious puberty. Pituitary 2009;12:335 - 8.
8. Happ J, Schultheib H, Jacobi GH, Wenderoth UK, Buttenschon K, et al. Pharmacodynamics, pharmacokinetics and bioavailability of the prolonged LH-RH agonist Decapeptyl - SR. In: Klipp Jan GM, editor. Hormonal manipulation of cancer. Peptides growth factors and new (anti) steroidal agents. New York: Raven Press, 1987:249 - 53.
9. Lahlou N, Carel JC, Chaussain JL, Roger M. Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics. J Pediatr Endocrinol Metab 2000;13:723 - 37.
10. Roger M, Chaussain J-L, Berlier P, Bost M, Canlorbe P, et al. Long-term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp-6-LHRH microcapsules. J Clin Endocrinol Metab 1986;62:670 - 7.
11. Bhatia S, Neely EK, Wilson DM. Serum luteinizing hormone rises within minutes after depot leuprolide injection: implications for monitoring therapy. Pediatrics 2002;109:e30 - 6.
12. Poomthavorn P, Khlairit P, Mahachoklertwattana P. Subcutaneous gonadotropin-releasing hormone agonist (triptorelin) test for diagnosing precocious puberty. Horm Res 2009;72:114 - 9.
13. Kunz GJ, Sherman TI, Klein KO. Luteinizing hormone (LH) and estradiol suppression and growth in girls with central precocious puberty: is more suppression better ? Are pre-injection LH levels useful in monitoring treatment ? J Clin Endocrinol Metab 2007;20: 1189 - 98.